FLUZONE TIV SH 2026

Sanofi Vaccines US Inc.🇺🇸 United States

FDA Page

Effective Date: Apr 30, 2026
Approval ID: ced9a8b6-ef2c-a620-c61c-ff9374249543
Products: 0 registered
Version: 8

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Fluzone Southern Hemisphere safely and effectively. See full prescribing information for Fluzone Southern Hemisphere. Fluzone (Influenza Vaccine) injectable suspension, for intramuscular use 2026 Formula Initial U.S. Approval: 1980

Quick Stats

Total Products0

Labelers1

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.